Lexicon Pharmaceuticals, Inc.
3 drugs in NADAC|0 Generic,3 Brand
Lexicon Pharmaceuticals, Inc. lists 3 NDCs in the CMS NADAC file (0 generic, 3 brand), at an average NADAC of $20.16 per unit, with a week-over-week move of -0.4% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
3
0G / 3B
Avg Price / Unit
$20.1582
$19.74 – $20.37
Avg 7d Change
-0.44%
Across 2 drugs with changes
7d Activity
of 3 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
sotagliflozin market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Sodium-Glucose Cotransporter 2 Inhibitor therapeutic class
Review the broader class where Lexicon Pharmaceuticals, Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Lexicon Pharmaceuticals, Inc. make?
Lexicon Pharmaceuticals, Inc. lists 3 NDCs in the CMS NADAC file — 0 generic and 3 brand products.
What is the average price of Lexicon Pharmaceuticals, Inc. drugs?
The average NADAC across Lexicon Pharmaceuticals, Inc.'s portfolio is $20.1582 per unit, ranging from $19.7358 to $20.3694.
What types of drugs does Lexicon Pharmaceuticals, Inc. make?
Lexicon Pharmaceuticals, Inc. makes drugs across 1 FDA pharmacologic class. The most common by NDC count are Sodium-Glucose Cotransporter 2 Inhibitor (3).
Has Lexicon Pharmaceuticals, Inc. had any drug recalls?
No FDA enforcement recalls are matched to Lexicon Pharmaceuticals, Inc. in the openFDA feed.
How has Lexicon Pharmaceuticals, Inc.'s pricing changed recently?
Over the past 7 days, 0 Lexicon Pharmaceuticals, Inc. products rose and 2 fell, with a portfolio-wide average change of -0.4%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
INPEFA 200 MG TABLET sotagliflozin | $20.3694 per EA | -0.44% |
INPEFA 200 MG TABLET sotagliflozin | $20.3694 per EA | -0.44% |
INPEFA 200 MG TABLET sotagliflozin | $19.7358 per EA | — |